| Protein Processing | ELISA | Cell surface expression (Flow cytometry) | Cell fusion (% of WT) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
 |  | Cell surface protein (Non-permeabilized) | Total protein (permeabilized) | Palivizumab | 47F | 101F | mAb19 | 32°C | 37°C | 39.5°C |
Wild-type | complete | 100 | 100 | 100 | 100 | 100 | 100 | 100% | 100% | 100% |
C37S | minimal | 0.00 | 51 | 7 | 3 | 2 | 4 | 8% | 8% | 12% |
C69S | reduced | 25 | 72 | 22 | 19 | 21 | 20 | 10% | 12% | 12% |
C212S | complete | 117 | 103 | 37 | 43 | 46 | 39 | 52% | 44% | 34% |
C313S | reduced | 3 | 44 | 23 | 11 | 4 | 1 | 6% | 5% | 5% |
C322S | minimal | 0 | 35 | 5 | 1 | 3.5 | 0 | 7% | 5% | 6.5% |
C333S | minimal | 0 | 41 | 8 | 3 | 3 | 0.5 | 12% | 8.5% | 10% |
C343S | minimal | 0 | 22 | 4 | 0 | 1.5 | 0 | 14% | 17% | 19% |
C358S | minimal | 0 | 17 | 3 | 0 | 2 | 0 | 7% | 4% | 6% |
C367S | minimal | 0 | 8 | 8 | 3 | 9 | 1.5 | 10% | 8% | 9% |
C382S | complete | 103 | 90 | 86 | 102 | 96 | 88 | 105% | 91% | 100% |
C393S | reduced | 8 | 42 | 13 | 10 | 13 | 7 | 14% | 10% | 12% |
C416S | minimal | 0 | 43 | 4 | 3 | 5 | 0 | 5.5% | 4% | 4% |
C422S | complete | 141 | 132 | 90 | 93 | 81 | 81 | 140% | 122% | 146% |
C439S | minimal | 0.4 | 26 | 7 | 4 | 4 | 1 | 50% | 29% | 30% |